Engineered small non-antibody protein scaffolds are a promising alternative to antibodies and are especially attractive for use in protein therapeutics and diagnostics. The advantages include smaller size and a more robust, single-domain structural framework with a defined binding surface amenable to mutation. This calls for a more systematic approach in designing new scaffolds suitable for use in one or more methods of directed evolution. We hereby describe a process based on an analysis of protein structures from the Protein Data Bank and their experimental examination. The candidate protein scaffolds were subjected to a thorough screening including computational evaluation of the mutability, and experimental determination of their expression yield in E. coli, solubility, and thermostability. In the next step, we examined several variants of the candidate scaffolds including their wild types and alanine mutants. We proved the applicability of this systematic procedure by selecting a monomeric single-domain human protein with a fold different from previously known scaffolds. The newly developed scaffold, called ProBi (Protein Binder), contains two independently mutable surface patches. We demonstrated its functionality by training it as a binder against human interleukin-10, a medically important cytokine. The procedure yielded scaffold-related variants with nanomolar affinity.

Institute of Biotechnology of the Czech Academy of Sciences BIOCEV CZ 25250 Vestec Czech Republic

Zobrazit více v PubMed

Bryson J.W., Desjarlais J.R., Handel T.M., DeGrado W.F. From coiled coils to small globular proteins: Design of a native-like three-helix bundle. Protein Sci. 1998;7:1404–1414. doi: 10.1002/pro.5560070617. PubMed DOI PMC

Khoury G.A., Smadbeck J., Kieslich C.A., Floudas C.A. Protein folding and de novo protein design for biotechnological applications. Trends Biotechnol. 2014;32:99–109. doi: 10.1016/j.tibtech.2013.10.008. PubMed DOI PMC

Burnside D., Schoenrock A., Moteshareie H., Hooshyar M., Basra P., Hajikarimlou M., Dick K., Barnes B., Kazmirchuk T., Jessulat M., et al. In Silico Engineering of Synthetic Binding Proteins from Random Amino Acid Sequences. iScience. 2019;11:375–387. doi: 10.1016/j.isci.2018.11.038. PubMed DOI PMC

Kortemme T., Baker D. Computational design of protein-protein interactions. Curr. Opin. Chem. Biol. 2004;8:91–97. doi: 10.1016/j.cbpa.2003.12.008. PubMed DOI

Mikulecky P., Cerny J., Biedermannova L., Petrokova H., Kuchar M., Vondrasek J., Maly P., Sebo P., Schneider B. Increasing affinity of interferon-gamma receptor 1 to interferon-gamma by computer-aided design. BioMed Res. Int. 2013;2013:752514. doi: 10.1155/2013/752514. PubMed DOI PMC

Smith G.P., Petrenko V.A. Phage Display. Chem. Rev. 1997;97:391–410. doi: 10.1021/cr960065d. PubMed DOI

Hosse R.J., Rothe A., Power B.E. A new generation of protein display scaffolds for molecular recognition. Protein Sci. 2006;15:14–27. doi: 10.1110/ps.051817606. PubMed DOI PMC

Brender J.R., Shultis D., Khattak N.A., Zhang Y. An Evolution-Based Approach to De Novo Protein Design. Methods Mol. Biol. 2017;1529:243–264. PubMed PMC

Goldenzweig A., Goldsmith M., Hill S.E., Gertman O., Laurino P., Ashani Y., Dym O., Unger T., Albeck S., Prilusky J., et al. Automated Structure- and Sequence-Based Design of Proteins for High Bacterial Expression and Stability. Mol. Cell. 2016;63:337–346. doi: 10.1016/j.molcel.2016.06.012. PubMed DOI PMC

Musil M., Stourac J., Bendl J., Brezovsky J., Prokop Z., Zendulka J., Martinek T., Bednar D., Damborsky J. FireProt: Web server for automated design of thermostable proteins. Nucleic Acids Res. 2017;45:W393–W399. doi: 10.1093/nar/gkx285. PubMed DOI PMC

Zahradnik J., Kolarova L., Peleg Y., Kolenko P., Svidenska S., Charnavets T., Unger T., Sussman J.L., Schneider B. Flexible regions govern promiscuous binding of IL-24 to receptors IL-20R1 and IL-22R1. FEBS J. 2019;286:3858–3873. doi: 10.1111/febs.14945. PubMed DOI

Banta S., Dooley K., Shur O. Replacing antibodies: Engineering new binding proteins. Annu. Rev. Biomed. Eng. 2013;15:93–113. doi: 10.1146/annurev-bioeng-071812-152412. PubMed DOI

Yu X., Yang Y.P., Dikici E., Deo S.K., Daunert S. Beyond Antibodies as Binding Partners: The Role of Antibody Mimetics in Bioanalysis. Annu. Rev. Anal. Chem. 2017;10:293–320. doi: 10.1146/annurev-anchem-061516-045205. PubMed DOI PMC

Skerra A. Engineered protein scaffolds for molecular recognition. J. Mol. Recognit. 2000;13:167–187. doi: 10.1002/1099-1352(200007/08)13:4<167::AID-JMR502>3.0.CO;2-9. PubMed DOI

Hey T., Fiedler E., Rudolph R., Fiedler M. Artificial, non-antibody binding proteins for pharmaceutical and industrial applications. Trends Biotechnol. 2005;23:514–522. doi: 10.1016/j.tibtech.2005.07.007. PubMed DOI

Simeon R., Chen Z. In vitro-engineered non-antibody protein therapeutics. Protein Cell. 2018;9:3–14. doi: 10.1007/s13238-017-0386-6. PubMed DOI PMC

Nord K., Gunneriusson E., Ringdahl J., Stahl S., Uhlen M., Nygren P.A. Binding proteins selected from combinatorial libraries of an alpha-helical bacterial receptor domain. Nat. Biotechnol. 1997;15:772–777. doi: 10.1038/nbt0897-772. PubMed DOI

Binz H.K., Amstutz P., Pluckthun A. Engineering novel binding proteins from nonimmunoglobulin domains. Nat. Biotechnol. 2005;23:1257–1268. doi: 10.1038/nbt1127. PubMed DOI

Skerra A. Alternative non-antibody scaffolds for molecular recognition. Curr. Opin. Biotechnol. 2007;18:295–304. doi: 10.1016/j.copbio.2007.04.010. PubMed DOI

Barinka C., Ptacek J., Richter A., Novakova Z., Morath V., Skerra A. Selection and characterization of Anticalins targeting human prostate-specific membrane antigen (PSMA) Protein Eng. Des. Select. 2016;29:105–115. doi: 10.1093/protein/gzv065. PubMed DOI

Bedford R., Tiede C., Hughes R., Curd A., McPherson M.J., Peckham M., Tomlinson D.C. Alternative reagents to antibodies in imaging applications. Biophys. Rev. 2017;9:299–308. doi: 10.1007/s12551-017-0278-2. PubMed DOI PMC

Rothe C., Skerra A. Anticalin((R)) Proteins as Therapeutic Agents in Human Diseases. BioDrugs. 2018;32:233–243. doi: 10.1007/s40259-018-0278-1. PubMed DOI PMC

Kosztyu P., Kuchar M., Cerny J., Barkocziova L., Maly M., Petrokova H., Czernekova L., Liskova V., Raskova Kafkova L., Knotigova P., et al. Proteins mimicking epitope of HIV-1 virus neutralizing antibody induce virus-neutralizing sera in mice. EBioMedicine. 2019;47:247–256. doi: 10.1016/j.ebiom.2019.07.015. PubMed DOI PMC

Vazquez-Lombardi R., Phan T.G., Zimmermann C., Lowe D., Jermutus L., Christ D. Challenges and opportunities for non-antibody scaffold drugs. Drug Discov. Today. 2015;20:1271–1283. doi: 10.1016/j.drudis.2015.09.004. PubMed DOI

Azhar A., Ahmad E., Zia Q., Rauf M.A., Owais M., Ashraf G.M. Recent advances in the development of novel protein scaffolds based therapeutics. Int. J. Biol. Macromol. 2017;102:630–641. doi: 10.1016/j.ijbiomac.2017.04.045. PubMed DOI

Ahmad J.N., Li J., Biedermannova L., Kuchar M., Sipova H., Semeradtova A., Cerny J., Petrokova H., Mikulecky P., Polinek J., et al. Novel high-affinity binders of human interferon gamma derived from albumin-binding domain of protein G. Proteins. 2012;80:774–789. doi: 10.1002/prot.23234. PubMed DOI

Kuchar M., Vankova L., Petrokova H., Cerny J., Osicka R., Pelak O., Sipova H., Schneider B., Homola J., Sebo P., et al. Human interleukin-23 receptor antagonists derived from an albumin-binding domain scaffold inhibit IL-23-dependent ex vivo expansion of IL-17-producing T-cells. Proteins. 2014;82:975–989. doi: 10.1002/prot.24472. PubMed DOI PMC

Kruziki M.A., Bhatnagar S., Woldring D.R., Duong V.T., Hackel B.J. A 45-Amino-Acid Scaffold Mined from the PDB for High-Affinity Ligand Engineering. Chem. Biol. 2015;22:946–956. doi: 10.1016/j.chembiol.2015.06.012. PubMed DOI PMC

Alsultan A.M., Chin D.Y., Howard C.B., de Bakker C.J., Jones M.L., Mahler S.M. Beyond Antibodies: Development of a Novel Protein Scaffold Based on Human Chaperonin 10. Sci. Rep. 2016;5:37348. doi: 10.1038/srep37348. PubMed DOI PMC

Berman H.M., Battistuz T., Bhat T.N., Bluhm W.F., Bourne P.E., Burkhardt K., Feng Z., Gilliland G.L., Iype L., Jain S., et al. The Protein Data Bank. Acta Crystallogr. D Biol. Crystallogr. 2002;58 Pt 6:899–907. doi: 10.1107/S0907444902003451. PubMed DOI

El Kasmi K.C., Smith A.M., Williams L., Neale G., Panopoulos A.D., Watowich S.S., Hacker H., Foxwell B.M., Murray P.J. Cutting edge: A transcriptional repressor and corepressor induced by the STAT3-regulated anti-inflammatory signaling pathway. J. Immunol. 2007;179:7215–7219. doi: 10.4049/jimmunol.179.11.7215. PubMed DOI

Asadullah K., Sterry W., Volk H.D. Interleukin-10 therapy—Review of a new approach. Pharmacol. Rev. 2003;55:241–269. doi: 10.1124/pr.55.2.4. PubMed DOI

Liu Y., de Waal Malefyt R., Briere F., Parham C., Bridon J.M., Banchereau J., Moore K.W., Xu J. The EBV IL-10 homologue is a selective agonist with impaired binding to the IL-10 receptor. J. Immunol. 1997;158:604–613. PubMed

Larkin M.A., Blackshields G., Brown N.P., Chenna R., McGettigan P.A., McWilliam H., Valentin F., Wallace I.M., Wilm A., Lopez R., et al. Clustal W and Clustal X version 2.0. Bioinformatics. 2007;23:2947–2948. doi: 10.1093/bioinformatics/btm404. PubMed DOI

Okonechnikov K., Golosova O., Fursov M., Ugene Team Unipro UGENE: A unified bioinformatics toolkit. Bioinformatics. 2012;28:1166–1167. doi: 10.1093/bioinformatics/bts091. PubMed DOI

Schymkowitz J., Borg J., Stricher F., Nys R., Rousseau F., Serrano L. The FoldX web server: An online force field. Nucleic Acids Res. 2005;33:W382–W388. doi: 10.1093/nar/gki387. PubMed DOI PMC

Mikulecky P., Zahradnik J., Kolenko P., Cerny J., Charnavets T., Kolarova L., Necasova I., Pham P.N., Schneider B. Crystal structure of human interferon-gamma receptor 2 reveals the structural basis for receptor specificity. Acta Crystallogr. D Struct. Biol. 2016;72 Pt 9:1017–1025. doi: 10.1107/S2059798316012237. PubMed DOI PMC

Kabsch W. Xds. Acta Crystallogr. D Biol. Crystallogr. 2010;66 Pt 2:125–132. doi: 10.1107/S0907444909047337. PubMed DOI PMC

Evans P.R., Murshudov G.N. How good are my data and what is the resolution? Acta Crystallogr. D Biol. Crystallogr. 2013;69 Pt 7:1204–1214. doi: 10.1107/S0907444913000061. PubMed DOI PMC

Winn M.D., Ballard C.C., Cowtan K.D., Dodson E.J., Emsley P., Evans P.R., Keegan R.M., Krissinel E.B., Leslie A.G., McCoy A., et al. Overview of the CCP4 suite and current developments. Acta Crystallogr. D Biol. Crystallogr. 2011;67 Pt 4:235–242. doi: 10.1107/S0907444910045749. PubMed DOI PMC

McCoy A.J., Grosse-Kunstleve R.W., Adams P.D., Winn M.D., Storoni L.C., Read R.J. Phaser crystallographic software. J. Appl. Crystallogr. 2007;40 Pt 4:658–674. doi: 10.1107/S0021889807021206. PubMed DOI PMC

Horejsi Z., Stach L., Flower T.G., Joshi D., Flynn H., Skehel J.M., O’Reilly N.J., Ogrodowicz R.W., Smerdon S.J., Boulton S.J. Phosphorylation-dependent PIH1D1 interactions define substrate specificity of the R2TP cochaperone complex. Cell Rep. 2014;7:19–26. doi: 10.1016/j.celrep.2014.03.013. PubMed DOI PMC

Murshudov G.N., Skubak P., Lebedev A.A., Pannu N.S., Steiner R.A., Nicholls R.A., Winn M.D., Long F., Vagin A.A. REFMAC5 for the refinement of macromolecular crystal structures. Acta Crystallogr. D Biol. Crystallogr. 2011;67 Pt 4:355–367. doi: 10.1107/S0907444911001314. PubMed DOI PMC

Emsley P., Lohkamp B., Scott W.G., Cowtan K. Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 2010;66 Pt 4:486–501. doi: 10.1107/S0907444910007493. PubMed DOI PMC

Williams C.J., Headd J.J., Moriarty N.W., Prisant M.G., Videau L.L., Deis L.N., Verma V., Keedy D.A., Hintze B.J., Chen V.B., et al. MolProbity: More and better reference data for improved all-atom structure validation. Protein Sci. 2018;27:293–315. doi: 10.1002/pro.3330. PubMed DOI PMC

Dreier B., Pluckthun A. Ribosome display: A technology for selecting and evolving proteins from large libraries. Methods Mol. Biol. 2011;687:283–306. PubMed

Zahnd C., Amstutz P., Pluckthun A. Ribosome display: Selecting and evolving proteins in vitro that specifically bind to a target. Nat. Methods. 2007;4:269–279. doi: 10.1038/nmeth1003. PubMed DOI

Lam S.Y., Yeung R.C., Yu T.H., Sze K.H., Wong K.B. A rigidifying salt-bridge favors the activity of thermophilic enzyme at high temperatures at the expense of low-temperature activity. PLoS Biol. 2011;9:e1001027. doi: 10.1371/journal.pbio.1001027. PubMed DOI PMC

Armstrong E.H., Goswami D., Griffin P.R., Noy N., Ortlund E.A. Structural basis for ligand regulation of the fatty acid-binding protein 5, peroxisome proliferator-activated receptor beta/delta (FABP5-PPARbeta/delta) signaling pathway. J. Biol. Chem. 2014;289:14941–14954. doi: 10.1074/jbc.M113.514646. PubMed DOI PMC

Cheung Y.Y., Lam S.Y., Chu W.K., Allen M.D., Bycroft M., Wong K.B. Crystal structure of a hyperthermophilic archaeal acylphosphatase from Pyrococcus horikoshii—Structural insights into enzymatic catalysis, thermostability, and dimerization. Biochemistry. 2005;44:4601–4611. doi: 10.1021/bi047832k. PubMed DOI

Kumagai A., Ando R., Miyatake H., Greimel P., Kobayashi T., Hirabayashi Y., Shimogori T., Miyawaki A. A bilirubin-inducible fluorescent protein from eel muscle. Cell. 2013;153:1602–1611. doi: 10.1016/j.cell.2013.05.038. PubMed DOI

Vorup-Jensen T., Ostermeier C., Shimaoka M., Hommel U., Springer T.A. Structure and allosteric regulation of the alpha X beta 2 integrin I domain. Proc. Natl. Acad. Sci. USA. 2003;100:1873–1878. doi: 10.1073/pnas.0237387100. PubMed DOI PMC

Buchko G.W., Ni S., Robinson H., Welsh E.A., Pakrasi H.B., Kennedy M.A. Characterization of two potentially universal turn motifs that shape the repeated five-residues fold—Crystal structure of a lumenal pentapeptide repeat protein from Cyanothece 51142. Protein Sci. 2006;15:2579–2595. doi: 10.1110/ps.062407506. PubMed DOI PMC

McKay D.B., Xi L., Barthel K.K.B., Cech T.R. Structure and function of steroid receptor RNA activator protein, the proposed partner of SRA noncoding RNA. J. Mol. Biol. 2014;426:1766–1785. doi: 10.1016/j.jmb.2014.01.006. PubMed DOI PMC

Kanagawa M., Satoh T., Ikeda A., Nakano Y., Yagi H., Kato K., Kojima-Aikawa K., Yamaguchi Y. Crystal structures of human secretory proteins ZG16p and ZG16b reveal a Jacalin-related beta-prism fold. Biochem. Biophys. Res. Commun. 2011;404:201–205. doi: 10.1016/j.bbrc.2010.11.093. PubMed DOI

Becker A.K., Mikolajek H., Paulsson M., Wagener R., Werner J.M. A structure of a collagen VI VWA domain displays N and C termini at opposite sides of the protein. Structure. 2014;22:199–208. doi: 10.1016/j.str.2013.06.028. PubMed DOI PMC

Groves M.A., Osbourn J.K. Applications of ribosome display to antibody drug discovery. Expert Opin. Biol. Ther. 2005;5:125–135. doi: 10.1517/14712598.5.1.125. PubMed DOI

Pluckthun A. Ribosome display: A perspective. Methods Mol. Biol. 2012;805:3–28. PubMed

Bohm G., Muhr R., Jaenicke R. Quantitative analysis of protein far UV circular dichroism spectra by neural networks. Protein Eng. 1992;5:191–195. doi: 10.1093/protein/5.3.191. PubMed DOI

Lefevre F., Remy M.H., Masson J.M. Alanine-stretch scanning mutagenesis: A simple and efficient method to probe protein structure and function. Nucleic Acids Res. 1997;25:447–448. doi: 10.1093/nar/25.2.447. PubMed DOI PMC

Weiss G.A., Watanabe C.K., Zhong A., Goddard A., Sidhu S.S. Rapid mapping of protein functional epitopes by combinatorial alanine scanning. Proc. Natl. Acad. Sci. USA. 2000;97:8950–8954. doi: 10.1073/pnas.160252097. PubMed DOI PMC

Morrison K.L., Weiss G.A. Combinatorial alanine-scanning. Curr. Opin. Chem. Biol. 2001;5:302–307. doi: 10.1016/S1367-5931(00)00206-4. PubMed DOI

Miknis Z.J., Magracheva E., Li W., Zdanov A., Kotenko S.V., Wlodawer A. Crystal structure of human interferon-lambda1 in complex with its high-affinity receptor interferon-lambdaR1. J. Mol. Biol. 2010;404:650–664. doi: 10.1016/j.jmb.2010.09.068. PubMed DOI PMC

Jerabek-Willemsen M., Wienken C.J., Braun D., Baaske P., Duhr S. Molecular interaction studies using microscale thermophoresis. Assay Drug Dev. Technol. 2011;9:342–353. doi: 10.1089/adt.2011.0380. PubMed DOI PMC

Moretti R., Lyskov S., Das R., Meiler J., Gray J.J. Web-accessible molecular modeling with Rosetta: The Rosetta Online Server that Includes Everyone (ROSIE) Protein Sci. 2018;27:259–268. doi: 10.1002/pro.3313. PubMed DOI PMC

Hibbert E.G., Dalby P.A. Directed evolution strategies for improved enzymatic performance. Microb. Cell Factories. 2005;4:29. doi: 10.1186/1475-2859-4-29. PubMed DOI PMC

Bloom J.D., Arnold F.H. In the light of directed evolution: Pathways of adaptive protein evolution. Proc. Natl. Acad. Sci. USA. 2009;106((Suppl. 1)):9995–10000. doi: 10.1073/pnas.0901522106. PubMed DOI PMC

Packer M.S., Liu D.R. Methods for the directed evolution of proteins. Nat. Rev. Genet. 2015;16:379–394. doi: 10.1038/nrg3927. PubMed DOI

Xiao H., Bao Z., Zhao H. High Throughput Screening and Selection Methods for Directed Enzyme Evolution. Ind. Eng. Chem. Res. 2015;54:4011–4020. doi: 10.1021/ie503060a. PubMed DOI PMC

Moraga I., Spangler J.B., Mendoza J.L., Gakovic M., Wehrman T.S., Krutzik P., Garcia K.C. Synthekines are surrogate cytokine and growth factor agonists that compel signaling through non-natural receptor dimers. eLife. 2017;6:e22882. doi: 10.7554/eLife.22882. PubMed DOI PMC

Diffraction anisotropy and paired refinement: crystal structure of H33, a protein binder to interleukin 10

Regulation of IL-24/IL-20R2 complex formation using photocaged tyrosines and UV light